FDA Approved: DOPTELET — Supplemental Application (AkaRx, Inc.)

View source ↗

Summary

FDA approved a supplemental application for DOPTELET (avatrombopag) by AkaRx, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Thrombocytopenia

Drugs mentioned

• DOPTELET (avatrombopag)

Snippet

SUPPL AP for DOPTELET (AVATROMBOPAG MALEATE)